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Angiographicaily significant and frequently severe coronary 
artery disease is prevalent among patients with aortic and 
peripheral atherosclerosis (I -6). This underlying coronary 
atherosclerotic disease predispows patients undergoing vascu- 
lar reconstructive surgical procedures to perioperative cardia: 
events (i-6). Over the past decade, extensive published re- 
ports haVc evaluated the use of preoperative clinical and 
noninvasive screening in thii population. The ultimate goal of 
thir approach has been to determine high risk subgroups who 
might benefit from alternative surgical or medical management 
stratcgics to improve pcrioperative outcomes (6). 
(J Am C&i lb&cd 199&27:761-p%) 
Clinical riik factors and the severity ot stress-induced 
noninvasive imaging abnormulities have been correlated with 
perioperative and late postoperative cardiac events (4.7-12). 
More wcemly, ischemie wall motion abnormalities on W 
dimensional echocardiography during dobutatrdne infkion 
have also been corrciated with perioperative cardii evettb 
(13-l 7). Developing empirically-based evidence from diverse 
study populations and imaging techniques into a clinical- 
imaging risk stratification algorithm has been dit?icuJt because 
several studies (IO-12,lg) have demonstrated a limited pre- 
dictive value of noninvasive imaging in this rtting. To this end, 
a me&analysis of the published reports on di@!amoie and 
dobutamine, stress myocardial imaging was performed to de- 
velop clinkal recommendations for risk stratikation of vasa~- 
lur surgical candidates. 
Methods 
Descrtptloa =d r)a*~ rrarrk. Ari&s were obtained using 
the National Lfijrary of Medicine MEDLINE data base be- 
tween 19% an.i 1994. From an initial search, a total of 43 
articles were obtained under a broad-based search algorithm 
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using the subject headings mdionuclide imuging, di~damole, 
preopetutive and comwtuy arrery disease. R total of 10 arhcles 
were rettuned for final rcvicw (7-12,18-21). A second search 
included articles published from IWO to IW4 on linked subject 
headings: abbutamik echacaniiqraphy and pmopemdve. A 
total of 5 articles on dobutamine cchocatdiography wctc: 
identified, excluding one duplicate patient series (13-17). 
Study &ctio~~. Inclusion criteria were I) English lan- 
guage; 2) peer-reviewed articles published between IW and 
1994: 3) only updated patient populations, delined as the latter 
of two publications from the same population; and 4) available 
cardiac event rates classified by noninvasive test results. Stud- 
ies reporting major general nonvascular surgeg results were 
excluded (22-26). Study end points (cardiac death, myocatdial 
infarction, recurrent ischcmia, congestive heart failure) were 
carefully scrutinized. 
Quality assessment criteria. A previously validated study 
quality grade was assigned 10 each report hy an invcstigrtol 
and independently reviewed a( two separate limes (27-20). 
Fitch report WHS tcviewcd for prticn( inclusion and cxclurion 
ctitctia, intcrvcnlion or ltcntment sttattigics used. study ucsipt 
and clinical and nonin&r dalu adlc~tcJ. Qunlity assessment 
criteria included (24i25) A) studies with broad gcnetallwbility 
(adeyuak sample hire, sutiicictli rud lmiul drfitriliuu and 
ascertainment) to a variety of patients, without siPnilicant flaws 
in rese,jrch methods (eap!icit research design. study inclusion 
and exclusion criteria; multivariable adjustment or njvatiate 
stratification); B) studies with a narrower spectrum of gener- 
alizability and with only a few flaws that arc well described such 
that their imp&? on omclusions can he assessed (borderlii 
sample size, sufficient end point definition and ascenainment; 
study design and methods include limited patient s&&a 
criteria, univatiable statisrics or missing key covariate adjust- 
ment); C) studies with several Paws in research methods (small 
sample sizes or incomplete repotting of stu* &tgn or 
methods); and D) studies with multiple flaws in tesearcb 
methods or rcpor~s of unsubstantiated opinion (case series 
containing ~10 palienN). Only studies graded A or B were 
included in the subsequcnl analyses. 
Evidatla tab&. Abstmcted data were compiled in, the 
form of standard evidence tables, detailing study design, 
clinical and test characteristics and st&y end points. An 
abn&mal stress scan response was defined as one or n&e 
fixed or reversible thallium-201 myocardial perfusion defects. 
A~I abnormal response to dobutamine was defined as new or 
wotsening vemriculat wall motion. 
Stat&t& ‘l’he cslimalcd odds ratio (95% confidence in- 
tctvnl) was bttsed on H tan&m &ecv m&l and ‘cllkula~ed 
usiny,FAST’PRO software @O-.12). lttitial FomparisoM made 
regarding the unblinding of imaging :est results revealed no 
differences in predictive estimates from blindsd to unblinded 
patient series (Table I). Goodness of fit correlation coefficients 
were calculated for changes in positive pt :dictive value sub- 
classified by the pretest probability of coronary artery disease. 
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Sample size estimates were based on a comparison of two 
proportions witt a one-sided Fisher exact lest (33). which 
yielded a necessary and sutficient sample Si of 191 patients at 
alpha 0.01 and heto 0.05. A backward stepwise logistic regres- 
aion was performed on tie dipyridamok-thallium-201 reports 
(7-12) thaw included clinical history fcongestnre heart failure, 
diabetes, angina, history of myocardial infarcticn, advanced 
age and male gender) and noninvasive test results (fixed or 
reversible thallium-201 defect). 
Results 
Intravenous KXpytidamole-Thallium-201 
Myocardia I Perfusiim Imaging 
Clloknl and study cbnrncierlutks. Results from a lotal of 
1,994 vascvlrr surgery candidates were reported in 1U qualify- 
ing reports (Tabk I). Only 4 of the 10 studies utilized some 
form of blinded test interpretation. Patients with congestive 
heart failure were excluded in three studies (7,18,1Y), patients 
with severe or persistent angina in one (10) and those under- 
going preoperative myccardial revascularization in three (IO- 
12). 
Patients were on average 66 2 9 years old, with a hip* 
pretest likelihood of prior mrcmicly drtcry dirasc (37.2% ) on 
the basts of a history of a prior myocrrdial infarction (32.5%)T 
amgestive heart failura (Il.Z%) or typical acgina pectori.. 
(32.1%) b&r vascular surgery (Table 2). Seventy-tluee per- 
cent of patients were men. 
Preopmtive tmtment altcntbo~ md postyncra~ne COP 
d&c w&r f’f’abk!~ 3 NWJ 4). Vasculur surgery was canceled in 
61 ot patirnts. primarily becx~se of Hugh cbnicrl risk or 
nonin&ve lest results. Twenty percent ol patients underwent 
preoperative coronary artcriography aftrr ducumentntion of 
one or more reversible perfusion defea;, and 5% and 4% of 
patients underwent preoperative and postopxatlve ml * .ardial 
revascularizition, respectively. 
Posroperurive cunlioc f~nfs included seconda- bi “soft” 
end points defined ES unstable angina, ischemic ST-T wave 
changes or congestive heart fai&re (Tables 3 and 4). Any such 
adverse event occurred in 12% of patients (range 7.2% to 
21.7%). Rates of cardiac death or nonfatal myocardial inlarc- 
tion were 2% and 4%, respectively. 
Dipyridamokthalkum-201 scan results were normal in 730 
patients (36%). Fii perfusion defects were seen in 471 
patients (240/n), and 793 (40%) had one or more reversible 
defect. Cardiac event rates were 3%. II% and lH% (chi-square 
51.7, p = O.OOOl), and cardiac death or myocardial infarction 
rates were 1%. 7% and 9% (chi-square 25.2, p = O.OQOl), for 
normal results, tixed defects and reversible defects on thallium- 
201 scans, respectively. Dipyridamole-induced ECG ST seg 
ment depression occurred in 7% of patients in four studies and 
was associated with overall and cardiac death or myocardii 
infarction rates of 27% and b’% (chi-square for any cardiac 
event 32.8, p = 0.0001; chi-square for death or myocardial 
infarction 8.6, p = 0.003). Summary odds ratios for prediction 
of cardiac events by thallium-W imaging results (Fig. 1) were 
3.5 (95% confidence interval [Cl] 2.5 to 4.8) for any ischemic 
event and 3.Y (05% Cl 2.5 to 5.6) for cardiac death or 
myocardial infarction. Heterogeneity statistics were nonsignif- 
icxnt, indic-ting homogeneity of the pooled data. 
~miguonti~th thallium-2U imagiog aoabbib. H’~~EII 
the cardiac event rate was evaluated by .urmiqtumtitative 
thallium-201 results derived from three reports (9,19,2(j), there 
wus a higher cardiac event rate in patients with two or .more 
(2Y.W 71 patients) than tho+x with one or more (l&4%, 215 
patients) reversible defects (chi-square 43.0, p = O.OiJOl). 
L+g-term card&e eveet rates. Long-term cardiac event 
rates derived in two studies (24.32) were 6.0% in 166 patients 
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with normal thallium-201 scan results. One- to 3-year cardiac Met&reglwssiuslofcilnknlaudislml#mglro*lrlebisl.Five 
event rates (including early perioperative events) were 34.8% trials provided event rates for various clinical and test result 
and 32.81, respectively, in 203 Patients with fixed and 220 with descriptors (i.e., percent of elderly, patients with a history of 
reversible thallium-201 defects (&i-square 50.6. p = 0.0001). myocardial infarction, typuxd angina peeto& or diabeteq or 
After early perioperative cardiac events were excluded later ECG abnormalities) (Table 2). These trials were organ&d 
event rates in patients with a fixed #feet were 1.4 times greater such thlr stepwise unhriate and m&variate lo&tic mgres- 
than in those with ~1 reversible thallium-201 defect (22.7% vs. sion analyses of pooled data could he perfomkd (7-11). High 
16.4%, chi-square 23.7, p = 0.0001). riskclinkalprediiors(aup<0.001)idenWfromtb#leBve 
FXect of pmupemtive rcwasdarltatfoa Figure 2 illus- reports imhded male gc;nder (67 [15.2%] of 441 patients). 
trates cardiac event rates classified according to the results of angina pectoris (65 p.6961 of 244 patients), history of myp 
dipyridamole-thallium-201 sintigraphy for the 1,994 patients cardial infarction (54 [22.O%] of 245 patients), cungestive heart 
evaluated in these studies. Of 57 patients who undetwent failure symptoms (II (33.0%] of 33 patients), diabetes (32 
preoprative myocardial revascularization, only 3 (6%) had a (16.8%]of lWpatien(s)andadvaccdaee(~65loaycux,67 
perioperative cardiac event, whereas of 527 patients who did (X6%] of 272 patients). The risk of isdcmic event 
not undergo coronary revascularization atIer detetion of a by clinical history was km& in male patients (odds ratio [OR] 
reversible defect, 9: (18%) had an event (chi-square 5.5, p = 0.78, p - 0.03) and was greatest in the elderly (OR 2.5, p = 
0.02). Overall cardiac event rates were 3.2% and 11.4% in 430 0.0001). For patients Gth a fixed thallium-201 myocardirrt 
and 347 patienta with normal scan results and fixed-only perfusiin defect, the odds ratio of a cardii event was I.6 (p - 
perfusion defects respectively (7,9,11,12,32). U.004) and increased 3..?.fold for patients with a re~eraib& 
!Mest ptu!.tnMlQ ofeventa. Pretest probability of cardiac thallium-201 myoatrdial perfuaiknt 
events was calculated based on previously documented an& M--P-w 
graphic or symptomatic clinical history of coronary dissase !I). The single greatest independent predicW of a periopetn- 
(Fig. 3). Population pretest probability differences au-related tive cardiac death 01 myocardiai infarction was the pnsencc of 
with the Positive predictive value of a reversible deftiT (r = a reversible myocardial pe&sion defect (p = 0.~1. OR 2.9). 
0.70). The Positive predictive value of an abnormal test result This was followed by sign: and symptoms of amgestk hccut 
increased 6.0 times between the patients with the lowest to failure (p = 0.0001. OR 3.6) and a fixed thallium-201 defect 
highest pretest probability of comnary artery disease. (P = O.ooOl, OR 2.7). A patient’s risk of a perioperative 
From a compilation of I76 palien’, from two series (I 1,12), cardiac event may be estimated by adding up the scores m the 
a negative clinical history for sips and symptoms of coronary last column of Table 5. 
ertery dincaM: was associated with low event rates, averaging 
1.1%. For 83 patients with a Positive clinical history for 
coronary artery disease, the cardiac event rate increased from Dobutrrmine Echosuniiagmphy 
4.8% for patients wit3 normal results or a tixed defect to 14.6% Mean sample size (Tabie 2) was smaller for dobutarnhbz 
for Y7 patients with a thallium-201 redistribution ahmaiity echotxdiographic studies lnan with diPyr&mole thallium- 
@hi-square 30.7, p = 0.0001). 201 imaging repo* (8Y vs. 199). Of patients undergoing 
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dobutamine echocardiography (Table 2), a lower frequency of 
typical angina (24%), congestive heart failure (6.5%) and 
diahctes (17.0%) was reported than for patients !mdergoing 
&pyrkiamole-th~m-201. 
lb&dive vaIar of Ic&emIc test resuks. A total of 36 
cardiac events were reported in 445 patients, Of which 17 
(47%) were cardiac death or nonfatal q yocardii infamtion. 
Per study, cardiac event rates ranged from 4.1% to 2!%. 
Nearly one-third of patients had a dobutie-i,-duced isch- 
emic response (range 3% to Xl%). As depicted in Fii 1, the 
univariate odds of any perioperative ischemic event ranged 
from 7.3 to 128.2-fold greater for patients with an abnormal 
than normal preoperative dobutamine stress echocardio- 
graphic response. By comparison, univariate odds of cardii 
death or myocardial infarction ranged from 4.0 to 28.5. Sum- 
mary odds ratios were 27.4 (95% CI 13.0 to 57.7) for any 
cardiac event and 14.6fold (95% CI 5.3 to 39.2) grezter for 
radiac death or nonfatal myocardial infarction. Tpsts for 
homogeneity were nonsignilicant for predictiig any event 
(chi-square 6.0, p = 0.19) and cardiac death or my- 
infarction (chi-square 2.5, p = 0.64). 
Figure 2 depicts the frequency of ischemic eventc by 
dobutamine stress-induced dys3ynergy. Qf t73 patients with a 
dobutamine-induced new or worsening wall motion response, 
40 (23.1%) had a perioperative ischemic event comI.xired with 
1 (0.37%) of 270 patients with a normal strm echocard+ 
graphic response @hi-square 64.9, p < 0.0001). The positive 
predictive valw of testing was 0.13 (range 0.07 to 0.21) for 
cardiac death or myor;rdial infarction aad 0.26 (range 0.17 to 
0.43) for any cardiac event. There was a weak relation between 
pretest probability of coronary artery disease and pcrioperatiie 
outcome (r = 0.16) (Fig. 3). The negative predictive value of a 
normal dobutamine echocardiographic response was 0.99 
(range 0.93 to 1.00). 
No cardiac events were reported in patients with an abnor- 
mal stress echocardiographii response who underwent preop- 
eratke reva.xuIarization (none of 21 patients), a 13-fold risk 
reduction @i-square 7.18, p = 0.007). Long-term (Z year) 
caroiac evenrs were reported in one series (‘7); the event rate 
was 2.9% for 69 patients with a nonnal .ti 15.0% for 20 with 
an abnormal stress ccbocardio~phic rtvult (chi-squxe 5.42, 
P = 0.319). 
Noainvasivc stress imag& co=pariso~ Summary odds 
ratios were greater for d&&amine echocardiography (11 to 
27) than for dipyridamo!e-thaIliurn-201 (3.7 to 4.0): 95% 
confidence intervals were wider with echocardiograpJhy as a 
result of smaller sample sizes (Fig. 4). The probabilie of a 
cardiac event was 0.23 (95S GO.07 to 0.19) ior dipyridamolc- 
:hallium-201 imagmg and 0.25 (USC, CI 0.16 to 0.33) for 
dobukmine echocardiography. 
The current report dernortirata the advantages of a rigor- 
ous r&a-anal?is of mlcrrandomized rriai reports on prcopx- 
atiw risk stratdication u.Gng ‘*XI *i&y I.IW~ imaging mod&- 
lAcCVd.Z?.No.4 
h&cb 15,1?%.787-98 
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Figwv3.Thereisartwd- 
era1cly strong (r 1 0.70) 
correlation fur positive pre- 
dictive value (PPV) of a re- 
versibk defect with the pre- 
ted probability of awomuy 
artery disease (CAD) web 
that the positive ~ediic 
value increases 5.93 times 
between the lowest and 
highest prier probability of 
wronay artery diiase. By 
comas& there is ncuxrefa- 
ticn (r = -0.16) between 
cardiac event miff, pretest 
probability of coronary ar- 
tery disease and the pcsitiw 
predik2ti.e value of an ab- 
twrnal dcbutamirte strti 
Wrerpwrre. 
artery disease is diit as a result of functional impairment raphy, left ventricular ejection fraction and ctinical risk factor 
and coexisti1.g diabetes (36) Shbdks attempting to clarify indices have been widely integrated into preoperative screen- 
preqeratlve and pcMoperative patient management strategies iog algorithms to predict significant coronary artery disease. 
have generally concluded that evidence of ischemic noninva- Pharmacologic noninvasive imaging has provided clinicians 
sive imaging is a crucial &terminanf of future risk. Although wtt data on which the decision for further surgical and 
some have argued for routine use of coronary arteriography in medical interventions may be based. Despite higher initial 
ail high risk patients (12), dipykbmok-thailium-231 scintig- imaging costs with pharmac&gic stress than with exercise, 
Tsbk 5. Logi& Regression Multivariahk Model for Predicting Pericqwative Cardiac Events (tive published reports for a total of 
1.188 patients) 
cardiac Bet.2 odd5 Rewtve 
step Total Evetx Rate CtIi-squuc coeulcien~ SE p Value Ratio ccarniliurl smre 
f&zxM4elhantum-201 I 404 225% 59.47 Isrl Il.14 O*Wll 2.93 29.91% 84 
s- 2 45 33.w 28.34 IM 0.25 OJNXJI 3.51 14.26? ICI 
F&l &Gum-201 3 IPI x47’, 2b.47 09 0.19 0.l1001 2.69 13..‘l% M 
.I*h”l 4 244 2b.64% 26.27 0.84 0.16 O.WJl 232 13.215 66 
ndeprrsr;la 5 133 27.82-i 2218 0.87 O.IR 0.0001 238 11.16C 69 
!+$wmdhl~mrn h 24s 22JMa Y).64 0.73 0.16 O.Mol 2.08 10.38% 57 
Eldnly 7 2-z 24.6S IO.61 I.01 0.31 O.QXl 2.74 5.34f; 80 
-gada II 441 15.19% 4.82 033 0.15 0.028 139 3.435 2b 
cmwiaol -231 0.11 
‘Duivcd~~cltL~10).Eykd~.(lI).Yuaaird~.(X~~dJ.(9).~berdal.(?).DiabstnrvonrineJfr~thcfrnalhadrw~d~lc~~eJsDo 
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ilb-I50 
-“.. 
r f (0.25). although the confdence range for this point estimate 
was wide becauu of the low number of patienti studied 
(Fig 4). 
Test results are afkted by a variety of UYZIWI~~~I and patient 
I II- vkdion di!Terences. For exampk, the specScity of e&xx- diopphic wall motion abnormalities is also adversely a&ted 
in the presence of an intermediate stenosis (50% to 70%), 
single-mael disease a: well as submaximal stress X0). Al- 
though single-photon emission computed tomographic 
(SPECT) imaging has been show 10 enhance detxtkm of 
coronary artery disease (41). three of the current reports 
(9,10,12) doarrnent a hir rate of false positive scan resuits. 
llx trend mward the use of increasingly wisitive but less 
sfkdlk rnyocadi imaging techno&y may influence the 
0 25 50 pC&he pWdktk Vah% of Peoperdh risk swihhcatin 
Plgum4 Summaiyoddsntiosand%% atatihm intervals for risk findiqp in future trials. 
stratifiration with dtannacdoek sues oerfmbn and eckardio- -of*t tRdieod ddbarcc Selected dinical 
rid markers that have been cone&ted with perioperative and 
postoperative events are widely utilized to triage patients 
for further testing T&se indude diabetes, (lt,l8,21.23) 
prior ntpcardial infarction (~11,19,43-45), aknmai electro- 
diognptuc results (43.44,4&47), con* heart faiie 
(19X&43,46,47), advanced age, (llJ223.44-48) angina 
7&J~,4648~ iyrhyhmb (11.43.44A449), prior woke 
. ilypmsm (46). By cclnwhg variables, several 
shaw and Miller (37), usiug secoudq e4mmmic analyses, dinid sm-ing indexes (4.11.43.44) have been generated using 
recently &owed that a strategy of preoperative risk stratifka- multivariabk~~Forenamp%,Eagleetai. 
tion with dipyridamole-thallium-201 ima& in addition to (11) identified five dinical wriabks &at were in&pen&at 
reducing peri~peratiw cardiac deaths (2%). is cost-effective rJIwkmof~cardiaceYen~advvrcedage(>7o 
compared wiih routine use of comnary a@ogq&y. A r;:, yean).EcGQvavesdiabetesmeuitus,~ofveotricuhr 
stmtial per  @&it COSt saviflg Was WXUU& -80%x when arrbyttnniasandhistoryofangina.onthebasisoftk?preYiou5 
preoperative rid, stratifkakfn included phamw&@z stress d of Eagle et al., our meta-- reports &2r a 
imaghg and selective cardiac catheterization ws ampad combined di&ak@ng preoperative a&ritha appears 
with direct catheterization in all wcular surgery camMa&. mostektiveini&ntifying*Thatis,forpatientswithone 
P&ktiW*OflB&lV&U~AWiderangeof orhvodinicalriskpredi&qthepresenceofthallirua-Bl 
predictive accuracies for noni- testing was enanmtered redhibutiondtmwtratedioawvotal~Yahke.Qf 
from these diverse studies. To examine the predi&iwe value of pient~ with ammary artery disease without and with a 
noninvasive testing, we collected avaitabk dinkal history and r&kt&&mperfusionobaonaality,cardiiewntrateswere 
nonimasivetesfdafahlivere~~rresuhsofa 11% and 23%. resoectivety. iqortaudri, dinkauy low rist 
multivariable regression model reveakd that the pwence of a patients~aneventrateofl18regardkS.ofthempcardial 
reversii myocardial perfusii defed was the 6ngIe greatest illlaging results (11.12). 
factor contributing to postoperative cardiac risk. Thi per- Further, nor&&w test performawe is influenced by the 
cent of the cumulative predii powv for adverse cardiac pretest dkease prevalence and the posttest likelihood d 
events was contrii by this finding, which was incmnental adverseeverrLs.TlleaNreutine~aramioed~~ 
andprovidedneadytwicethepredi&zinformatiouthanthe 
remainingdinicalortestvariablesinthemodei. 
p-cdk&lrmddstomorefuuyeaploretheidhlenadpaient 
diferenoesoilthe~Yahleoftiscnenlog 
In a large series of catheterized patients (38) the presence ~~~~~~if~~~ 
of stress-induced wall motion aknmalities provides s&tan- of~&!ow,tknscwningtestswillbeofkfitedvalue. 
lial independent predi&e informab ttqgdng inng-term i!IOlIClI%X~~Ofi,~puieatS(5).peiiqrenrtiverardiac 
wvivaiYmedica@treatedpatienrswitheorowya8tery deathofnonfaIai~iofarctionwas~nearly 
disease. Siikiy, in patients with a high pretest risk of sidddforpatloc6withcooqntedidlthose~twronaty 
coronarykrtetydii,theoddsofaperioperatkec2rdiac army disease. 
event wre elevated scyeafdd sod the “hard” ewnl rate ne.fombiaatnnof$ind~and~~asseas. 
increased’l4-fold,ia~tsWith~~tntt mcat,asbascdmthepreaenlnpaleabaecespr~*~ 
sientdsyner~(39).~or~waumution~- fkkaE.IBmsLOurresulrsfnnn10prbtirlndnzpats~ 
it&~rearaociatedwithohighpmhatGydacardiacevent t&attkp&tiuepre&ivevalueofareuMle 201 
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mvc~ardial oerfusion de:rt for cardiac evcut; is directly 
f&ptja$to the prior probability of d&ease iFig. 4). The 
collelatiort between pretest probability of disease aod posttest 
liklhod of cardiac Cwents was weak for five studies of 
d&ttaa&e strem echoardibgraphy. The pnsitive predictive 
vahte of a reversible thallium-2Ol defect was nearly six times 
greater in thme studies with the greatest average pretest 
pr&&iliiofc4xomuydisearcthanthosewithlowerpretest 
disease estimates. In thii dlnieally risk-adjusted anatysis, re- 
sults fmo d&yr&t&e perfusion imaging (i.e., ST depression 
and fixed and Imwxii defects) contained approxitnately half 
the predi power. 
me&eaiu~~toimpnwe- 
Ahhough there is an inherent procedural risk with coronary 
TeVBSfUlaTiZatiOSI, pnoled randomized trial data demonstrate 
that dinically high risk patients derive thp greatest sunival 
beneOtfromanonarybypassurgerythanOommedMther- 
spy and that this outcome difference persists up to 10 years 
(SO). Several nonrandomized studies (S-53) have suggested 
thatpre5perativeammaryrevascularizationmayreducethe 
riskofcardiacdeatbornonfatalmyoca&dinfatctionassoci- 
ati with Peripheral vwxuiar surgery by twofold to fourfold. 
Our synthesis of largely obsewational data reveals that a 
strategj of dinical noninvasive risk stratiOc~tion may be most 
effective if patients with an intermediate to high likelihood of 
an adverse event are identifkd an? then undergo intervention 
to redoce short- and long-term cardiac event risks Patients 
with a reversiie myocardii perfusion defe-;t ~zndergoing 
myucardial revamhhtion had an overall threefold reduc- 
tiottinri?&only3of51patieotsUdergu&coron~bypass 
surgetyorparcutaueousconmaryangi+&~tienceda 
Cardiac eveot (7-l 1). Preoperative coroxuy revascujarization 
wasequallyeffect&inmducingriskir~tbereportsondobut- 
p EIk&eMscularsurgelywascarl- 
zzn3%to6%of-ailpatientsbeLatSeofhighrisk 
sympornsornonitwasivetestresults.ltisalsofiossHethata 
cardiaceveotwasavertedinthesepatientsbecausetheresuhs 
0fthescreeuittgstrategiesusedledtomofeaggn+veanti- 
isckmicmedicaltherapyorconMatyrevasl~rization. 
Rwlkthovdirleuf forbteeJudiac 
eveats. Early studies (7,&19) using tole-thallimu-201 
imaging did not report an &eased rate of perioperative 
eveots in patients with hxed perfusion defecx lltc predictive 
vahJeofa4-bpost-stressfixeddefectbasincmasedstead@ 
omthepastdecade,inpattduetoelJlergiugdataontbe 
potentialforsevereischemiaiutbepmserKcofpetshtent 
thafhum-2Ol defects (SO). Forty-six percent of all cardia? 
evenu%muredinpatieotswith6xeddefeclsinonestudy(2O) 
attdimxeasedtherhk0fcardiacdeatbfourfoldinanother 
(21). Late cardii event rates were largely comparable in 
patients with fixed and revedbk defects with approx&tely 
omthird of patients with either defect pr&rn e~per&cirtg a 
eardfacevottt2to3yearsaftervasudarsurgery(&2&55).Th~ 
h~~~~-~~~~~~ 
ttmybelltuchgreateritlpa~witbr~defed, 
ittitlf&bm~eYentrateaareiadktktguish- 
able between a hxed or reversible thallium-201 defect. Sinilar 
predidive accuracy has been reported for exercise and dobut- 
amine stress echocardii (403). IO one dobutamine 
series (17) that reported l-year outaune data based on non- 
invasive imaging results, patients with a normal stress echocar- 
diogmphii response have a substantially lower ca~dii event 
rate than those with abnormal test results. 
Iinlitationsof~ Within a meta-arm&is (30) 
bias may arise when publicatioos with more extreme results are 
selected becauss they arc statistically signiticant. Precise de- 
tails of patient management during the iotraoperative time 
period were largely unavailable and may have led to imprecise 
estimates of the value of preoperative risk stratilicatioo strat- 
egies. Although we were abie to demonstrate that noninvasive 
risk stratification is valuable in the preoperative setting, a 
causui !Iok between preoperative ischemia and postoperative 
complications may not be inferred. Further. duplicate publica- 
tions from the same patient series would inappropriately 
weight a meta-analysis and were therefore exchtded (7,11,22, 
23,25+20,42+57-60). it i? reasmablc to assume that changes in 
patient referral patterns and posttest management occurred 
from 198 to 1994. A cfioical “training effect” may have 
mud&d referral tased on pretest hkefihood of coronary 
disease and, thus, posttest cardiac event tams and our predic- 
tive estimates 
-&ms. Fourkeyconch&ucanbederivedfromtbe 
pubbshed data on preoperative stress imaging iu vascular 
surpycaddakx l)TbepresemxofamversHed&&moL 
thallium-a01 myocardial perft&n defect has positive predii- 
tive wlw, but tbe aawacy of cardiac event predicnon varies 
withcorotlaty-&tydiseasepreva)ettceandthesymptomatic 
or risk factor profile of the study population. 2) Dobutamine- 
ioducededlocardiiphicwallmotionabnormalitiesarepre- 
dktiYe of adverse perioperative outcome& but with wide: 
ami%dence limits due to smaller sample sires in these studies. 
3) l%e use Of varying cutpoints, such as those used in se:,ii- 
quantitative image analys& may aid in risk identihcatiou of 
clinically lower and higher risk patients. 4) A tixed thallium- 
201 perfusion defect predius long-term cardiac events with 
accsracy equal to the predii value obsetved with a revers- 
iWe thallium-201 defect for perioperative events. 
These sumomry data substantiate the incremental predic- 
tive valw of 0 onimaske preoperative risk stratitication using 
phalmaoologicstressiomgiogiuYascularsurgerycandidates 
while chu%ying the infhtettce of patient covariables on test 
performam characteristics. Ibis analysk supports the ust of 
screening with dobutamine or dipyr&mo& @umaa&@ 
stress itraging in intermediate risk patients. Ahhough the past 
decadeofexperienLxdemoustratesth&dNgstruSimagingis 
anitttegraiaodvaluabiecumponentofthepreoperativepa- 
tientmanagementstrategy,futureresearchonneworexis+ 
tedmo&kSshouldbebusedonlargcpopulationstoenhance 
stzbtidpowerandtoJJemlittlle-preteststratifica- 
tbnofpatiemsllsxorditlgtotheiilikelikoodof 
eomyyvterydiseaseandserious~cveats 
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